Chairperson Day Time Room Page IS1 Methods of integrative mathematical oncology Takashi Suzuki Oct. 6 (Thu.) 9:00-11: Yu Shyr IS2 Wnt signaling

Transcription

1 Invited Sessions Chairperson Day Time Room Page SS1 Hitoshi Nakagama Oct. 6 (Thu.) 15:30-18: Kohei Miyazono SS2 Women scientists in cancer research Mari Kannagi Oct. 7 (Fri.) 12:50-15: Junko Takita Chairperson Day Time Room Page PD Tetsuo Noda Oct. 7 (Fri.) 15:30-18: Chairperson Day Time Room Page AACR1 Molecular targeted therapies for breast cancer Yoshio Miki Oct. 8 (Sat.) 9:00-11: José Baselga AACR2 Personalized treatments based on cancer genome profile Hiroyuki Mano Oct. 7 (Fri.) 9:00-11: Marc Ladanyi Chairperson Day Time Room Page CS1 Interplay between tumor heterogeneity and tumor microenvironment Hideyuki Saya Oct. 6 (Thu.) 9:00-11: Naoya Fujita CS2 Beyond the immune checkpoint blockade Yutaka Kawakami Oct. 7 (Fri.) 12:50-15: Yasuharu Nishimura CS3 Context-dependent TGF-β signaling and tumor progression Keiji Miyazawa Oct. 7 (Fri.) 12:50-15: TGF-β Mitsuyasu Kato CS4 Precision medicine: Genome and beyond Katsuya Tsuchihara Oct. 8 (Sat.) 14:40-17: Yoichi Furukawa Chairperson Day Time Room Page S1 DNA damage response and repair in cancer Makoto Nakanishi Oct. 6 (Thu.) 9:00-11: DNA Kozo Tanaka S2 ncrnas: A new paradigm in cancer pathogenesis, diagnosis and therapy Johji Inazawa Oct. 6 (Thu.) 9:00-11: RNA (ncrna) Tetsu Akiyama S3 New frontiers of hereditary cancer towards the precision medicine Yoshio Miki Oct. 6 (Thu.) 9:00-11: Yoshinori Murakami S4 Epigenetic therapeutic targets: Discovery and utilization Yutaka Kondo Oct. 6 (Thu.) 9:00-11: Toshikazu Ushijima S5 Development of the molecular-targeting drugs and their application to the clinical medicine Koichi Hagiwara Oct. 6 (Thu.) 12:50-15: Minoru Yoshida S6 Key signal transduction pathways in cancer development Jun-ichiro Inoue Oct. 6 (Thu.) 12:50-15: Hidenori Ichijo S7 Targeting metabolism in cancer Issay Kitabayashi Oct. 6 (Thu.) 12:50-15: Chiaki Takahashi S8 Basic aspects of cancer immunity Shimon Sakaguchi Oct. 7 (Fri.) 9:00-11: Koji Tamada S9 Biotherapy of cancer: New antibody therapeutics and oncolytic virus therapy Yasuhiro Matsumura Oct. 7 (Fri.) 9:00-11: Tomoki Todo S10 Therapeutic vulnerability in infection/inflammation-associated cancer Masanori Hatakeyama Oct. 7 (Fri.) 9:00-11: Masanobu Oshima S11 New development of pathological diagnosis for personalized medicine Wataru Yasui Oct. 7 (Fri.) 12:50-15: Atsushi Ochiai S12 Advances in cancer animal models: From mechanisms to clinical output Takuro Nakamura Oct. 7 (Fri.) 12:50-15: Akira Suzuki S13 Development, senescence and cancer Masahide Takahashi Oct. 7 (Fri.) 12:50-15: Tatsushi Igaki S14 Lessons from large scale cancer genome data Hiroyuki Aburatani Oct. 8 (Sat.) 9:00-11: Tatsuhiro Shibata S15 Development and application of advanced imaging techniques for cancer Takeshi Imamura Oct. 8 (Sat.) 9:00-11: Yasuteru Urano S16 Cancer metastasis: Beyond EMT Akira Kikuchi Oct. 8 (Sat.) 9:00-11: Tetsuro Watabe S17 The intestinal microflora and cancer Eiji Hara Oct. 8 (Sat.) 13:50-16: Toshiro Sato S18 Molecular basis of chromosome and genome instability in cancer Fuyuki Ishikawa Oct. 8 (Sat.) 13:50-16: Kiyoshi Miyagawa

2 Chairperson Day Time Room Page IS1 Methods of integrative mathematical oncology Takashi Suzuki Oct. 6 (Thu.) 9:00-11: Yu Shyr IS2 Wnt signaling as therapeutic targets Noriko Gotoh Oct. 6 (Thu.) 9:00-11: Wnt David M. Virshup IS3 Clinical sequencing with NGS panel for precision medicine Atsushi Ohtsu Oct. 6 (Thu.) 12:50-15: NGS precision medicine Patrick Tan IS4 Advances in Drug Delivery System (DDS) Nobuhiro Nishiyama Oct. 6 (Thu.) 12:50-15: Won Jong Kim IS5 Frontiers in genome engineering Yasuhiro Yamada Oct. 7 (Fri.) 9:00-11: Jin-Soo Kim IS6 Metabolic feature of cancers for anti-cancer therapy Hozumi Motohashi Oct. 7 (Fri.) 9:00-11: Young IL Yeom IS7 Liquid biopsy for cancer genome and precision medicine Hidewaki Nakagawa Oct. 7 (Fri.) 12:50-15: Liquid biopsy cfdna precision medicine Frank Diehl IS8 Non-coding RNA, a new epigenetic regulator in cancer Hiromu Suzuki Oct. 7 (Fri.) 12:50-15: Non-coding RNA Jong-Hoon Park IS9 New era of cancer immunotherapy Hiroyoshi Nishikawa Oct. 8 (Sat.) 9:00-11: Belinda S. Parker IS10 Like a bridge over troubled water: Inviting social scientists into controversies of health policies Yumiko Mochizuki Oct. 8 (Sat.) 9:00-11: Bruce Headey IS11 Tumor heterogeneity and clonal evolution: Focus on malignant brain tumors Akitake Mukasa Oct. 8 (Sat.) 13:50-16: Do-Hyun Nam IS12 Micro-environment of Asian common cancer Haruhiko Sugimura Oct. 8 (Sat.) 13:50-16: Yang-Sook Chun Chairperson Day Time Room Page SST1 Lung cancer translational science Hirotoshi Akita Oct. 6 (Thu.) 9:00-11: Translational Science Seiji Yano SST2 The latest medical research and development in gastrointestinal carcinoma Chikashi Ishioka Oct. 6 (Thu.) 12:50-15: Masaki Mori SST3 Exploring novel biomarkers for prostate cancer bridging basic research and clinical applications Mototsugu Oya Oct. 6 (Thu.) 12:50-15: Shigeo Horie SST4 Precision medicine in breast cancer - Current status and future perspective - Seigo Nakamura Oct. 7 (Fri.) 9:00-11: Precision Medicine - - Masakazu Toi SST5 Molecular targets in blood cancers - Taking new aim Shigeru Chiba Oct. 8 (Sat.) 9:00-11: Yuzuru Kanakura SST6 Integrated understanding and clinical development with genome research of childhood, adolescent and young adult cancer Keizo Horibe Oct. 8 (Sat.) 13:50-16: Miki Ohira Chairperson Day Time Room Page IC1 Introduction course for current cancer research 1 Toshiya Inaba Oct. 8 (Sat.) 9:00-11: Ryuichi Sakai IC2 Introduction course for current cancer research 2 Toshiaki Watanabe Oct. 8 (Sat.) 13:50-16: Hideaki Shimada INFORMATION DAY 1 AM LS PM Posters DAY 2 AM LS PM Posters DAY 3 AM LS PM Posters Chairperson Day Time Room Page SSP Survivor Scientist Program Tetsuo Noda Oct. 7 (Fri.) 15:50-17:20 P 195 INDEX Authors Keywords Chairpersons 15

3 Speaker/Chairperson Day Time Room Page ML1 Potential cancer therapeutics targeting TGF-β/Smad3 signaling Seong-Jin Kim Oct. 7 (Fri.) 8:00-8: Susumu Itoh ML2 RUNX genes: Integral component of Fanconi-BRCA pathway Yoshiaki Ito Oct. 7 (Fri.) 8:00-8: Rieko Ooki ML3 In Memoriam: Alfred G. Knudson Hereditary cancer & Environmental carcinogenesis Okio Hino Oct. 7 (Fri.) 8:00-8: Knudson 2 hit 45 Akira Orimo ML4 ASK family kinases in Stress Signaling and Cancer Hidenori Ichijo Oct. 7 (Fri.) 8:00-8: ASK Kohsuke Takeda ML5 From Real-time Tumor-Tracking Technology to Motion Science in Life Hiroki Shirato Oct. 7 (Fri.) 8:00-8: Masahiko Miura ML6 In situ Delivery and Production System(iDPS) to Target Hypoxia of Solid Cancers with Anaerobic Bifidobacterium Shun'ichiro Taniguchi Oct. 7 (Fri.) 8:00-8: Shinae Kondoh ML7 Recent Advances in Liquid Biopsy Masaki Mori Oct. 7 (Fri.) 8:00-8: Hidetoshi Tahara ML8 Trends in epigenetic drug discovery for anticancer therapy Minoru Yoshida Oct. 7 (Fri.) 8:00-8: Masaya Imoto ML9 Strategic development of combination cancer immunotherapies Kouji Matsushima Oct. 7 (Fri.) 8:00-8: Yataro Daigo ML10 Training Junior Scientists in Basic and Translational Cancer Research in the United States Ichiro Nakano Oct. 7 (Fri.) 8:00-8: Yasushi Ino ML11 Cancer genome sequence data analysis pipeline Genomon2 and Watson Genomic Analytics for clinical sequence Satoru Miyano Oct. 8 (Sat.) 8:00-8: Genomon2 Watson Genomic Analytics Yoshihiro Yamashita ML12 Hints for presenting your findings as an attractive paper Takashi Takahashi Oct. 8 (Sat.) 8:00-8: Yoshiro Maru ML13 Biological and clinical significance of CpG island methylator phenotype in cancer Hiromu Suzuki Oct. 8 (Sat.) 8:00-8: CpG Takashi Minami ML14 Therapeutics targeting the Wnt signaling pathway in colorectal cancer Tesshi Yamada Oct. 8 (Sat.) 8:00-8: Wnt Masaya Ono ML15 Pit-fall in development of cancer molecular target drugs Hiroyuki Osada Oct. 8 (Sat.) 8:00-8: Kazunori Aoki ML16 Development of a novel cancer immunotherapy targeting tumor microenvironment Takashi Matozaki Oct. 8 (Sat.) 8:00-8: Nobuyuki Takakura ML17 p53 pathway and cancer Takashi Tokino Oct. 8 (Sat.) 8:00-8: p53 Hiroshi Harada ML18 What is hormesis Fuyuki Ishikawa Oct. 8 (Sat.) 8:00-8: Hiroyuki Seimiya ML19 Alcohol and Cancer Risk Keitaro Matsuo Oct. 8 (Sat.) 8:00-8: Tomotaka Sobue ML20 Clinical and translational research for basic scientists Hideyuki Saya Oct. 8 (Sat.) 8:00-8: Atsushi Iwama ML21 Dissecting cancer biology with ips cell technology Yasuhiro Yamada Oct. 8 (Sat.) 8:00-8: ips Takumi Era ML22 Targeting TGF-β signaling in cancer Peter ten Dijke Oct. 8 (Sat.) 8:00-8: Shingo Maeda Chairperson Day Time Room Page IAL The Incitement Award Lectures Masashi Fukayama Oct. 8 (Sat.) 9:00-10: Chairperson Day Time Room Page YSAL Cancer Science Young Scientists Award Lectures Takashi Tokino Oct. 8 (Sat.) 10:30-11: Speaker/Chairperson Day Time Room Page MV1 Telomere maintenance system as an anticancer therapeutic target Hiroyuki Seimiya Oct. 7 (Fri.) 8:00-8: Ryuzo Ueda MV2 Cancer Genomics for Molecular Diagnosis and Treatment: Genome Sequencing and Genome-wide Association Study Hidewaki Nakagawa Oct. 8 (Sat.) 8:00-8: GWAS Okio Hino 16

4 Oral sessions 1 Chemical carcinogenesis and radiation carcinogenesis Day Time Room Page E1-1 DNA damage and carcinogenic process DNA Oct. 6 (Thu.) 12:50-14: E1-2 Inflammation and signaling Oct. 6 (Thu.) 14:05-15: J1-1 Carcinogenesis: interaction between with gene and environment Oct. 8 (Sat.) 10:15-11: Experimental animal models and genetically-engineered animals Day Time Room Page E2-1 Animal models of cancer (1) (1) Oct. 7 (Fri.) 9:00-10: J2-1 Animal models of cancer (2) (2) Oct. 7 (Fri.) 10:15-11: Virus, infection, inflammation and cancer Day Time Room Page E3-1 Infection, inflammation and gastroenterological cancer Oct. 7 (Fri.) 12:50-14: E3-2 HTLV-1, HPV, EBV HTLV-1 HPV EBV Oct. 7 (Fri.) 14:05-15: Oncogenes and tumor-suppressor genes Day Time Room Page E4-1 Wnt signaling Wnt Oct. 7 (Fri.) 10:15-11: E4-2 Cancer related genes (3) (3) Oct. 7 (Fri.) 12:50-14: E4-3 Cancer related genes (4) (4) Oct. 7 (Fri.) 14:05-15: E4-4 p53 signaling (1) p53 (1) Oct. 8 (Sat.) 9:00-10: J4-1 Ras gene, Wnt signal pathway Ras Wnt Oct. 7 (Fri.) 9:00-10: J4-2 Cancer related genes (1) (1) Oct. 7 (Fri.) 9:00-10: J4-3 Cancer related genes (2) (2) Oct. 7 (Fri.) 10:15-11: J4-4 p53 signaling (2) p53 (2) Oct. 8 (Sat.) 10:15-11: Signal transduction and gene expression Day Time Room Page E5-1 Signal transduction and regulation of gene expression (2) (2) Oct. 8 (Sat.) 9:00-10: E5-2 Signal transduction and regulation of gene expression (3) (3) Oct. 8 (Sat.) 10:15-11: J5-1 Signal transduction and regulation of gene expression (4) (4) Oct. 8 (Sat.) 13:50-15: J5-2 Signal transduction and regulation of gene expression (5) (5) Oct. 8 (Sat.) 15:05-16: DNA replication/cell cycle/genomic instability Day Time Room Page E6-1 DNA replication, cell cycle and genomic instability (1) DNA (1) Oct. 8 (Sat.) 9:00-10: J6-1 DNA replication, cell cycle and genomic instability (2) DNA (2) Oct. 8 (Sat.) 10:15-11: Cancer genome/genetics Day Time Room Page E7-1 Cancer genomics Oct. 6 (Thu.) 10:15-11: E7-2 Hereditary predisposition and genetics Oct. 6 (Thu.) 12:50-14: J7-1 Large-scale cancer data analysis Oct. 6 (Thu.) 9:00-10: Epigenetics Day Time Room Page E9-1 Epigenetic treatment Oct. 6 (Thu.) 14:05-15: E9-2 DNA methylation DNA Oct. 7 (Fri.) 12:50-14: E9-3 Chromatin associated protein Oct. 7 (Fri.) 14:05-15: J9-1 Epigenetic regulation Oct. 6 (Thu.) 12:50-14: Invasion and metastasis Day Time Room Page E10-1 Invasion and extracellular matrix Oct. 6 (Thu.) 9:00-10: E10-2 Invasion and gene expression Oct. 6 (Thu.) 10:15-11: E10-3 Invasion model and exosomes Oct. 7 (Fri.) 10:15-11: E10-4 Invasion and microenvironment Oct. 8 (Sat.) 15:05-16: J10-1 Angiogenesis and metastasis-related factors Oct. 7 (Fri.) 9:00-10: J10-2 Cell motility and imaging Oct. 8 (Sat.) 13:50-15: J10-3 Cell motility/invasion and EMT EMT Oct. 8 (Sat.) 13:50-15: Characteristics of cancer cells Day Time Room Page E11-1 Cell differentiation Oct. 6 (Thu.) 10:15-11: E11-2 Cancer stem cell (2) (2) Oct. 6 (Thu.) 10:15-11: E11-3 Cancer stem cell (3) (3) Oct. 6 (Thu.) 12:50-14: E11-4 Cancer stem cell (4) (4) Oct. 6 (Thu.) 14:05-15: E11-5 Cell-cell interaction, cell metabolism Oct. 8 (Sat.) 13:50-15: J11-1 Cancer stem cell (1) (1) Oct. 6 (Thu.) 9:00-10: J11-2 Cancer stem cell (5) (5) Oct. 7 (Fri.) 12:50-14: J11-3 Cancer malignancy and microenvironment Oct. 7 (Fri.) 14:05-15: J11-4 Glycosylation and metabolism Oct. 8 (Sat.) 15:05-16: INFORMATION DAY 1 AM LS PM Posters DAY 2 AM LS PM Posters DAY 3 AM LS PM Posters INDEX Authors Keywords Chairpersons 17

5 12 Cancer immunity Day Time Room Page E12-1 Cancer immunology (2): immunotherapy (2) Oct. 6 (Thu.) 10:15-11: E12-2 Cancer immunology (4): antitumor effector cell (4) Oct. 6 (Thu.) 14:05-15: E12-3 Cancer immunology (6): antitumor vaccine (6) Oct. 8 (Sat.) 13:50-15: E12-4 Cancer immunology (8): antibody therapy (8) Oct. 8 (Sat.) 13:50-15: E12-5 Cancer immunology (9): PD-1/PD-L1 passway (9) PD-1/PD-L1 Oct. 8 (Sat.) 15:05-16: J12-1 Cancer immunology (1): immune modulation (1) Oct. 6 (Thu.) 9:00-10: J12-2 Cancer immunology (3): augmentation of antitumor immune-responses (3) Oct. 6 (Thu.) 12:50-14: J12-3 Cancer immunology (5): immune-biomarkers and clinical trials (5) Oct. 6 (Thu.) 12:50-14: J12-4 Cancer immunology (7): application of new technology and concept for cancer immunology (7) Oct. 8 (Sat.) 15:05-16: Growth factors/cytokines/hormones Day Time Room Page E13-1 Signal transduction and regulation of gene expression (1) (1) Oct. 6 (Thu.) 9:00-10: Cancer basic, diagnosis and treatment Day Time Room Page E14-1 Hepato-biliary-pancreatic cancer: translational research Oct. 6 (Thu.) 10:15-11: E14-2 Translational research in urothelial cancer Oct. 6 (Thu.) 10:15-11: E14-3 Immune-oncology Oct. 6 (Thu.) 14:05-15: E14-4 Basic and clinical research of cancer Oct. 6 (Thu.) 14:05-15: E14-5 Molecular targeting therapy for lung cancer Oct. 6 (Thu.) 12:50-14: E14-6 Translational research in ovarian and endometrial cancer Oct. 7 (Fri.) 9:00-10: E14-7 Gastrointestinal cancer: basic research Oct. 7 (Fri.) 9:00-10: E14-8 Therapeutic strategies in hematological malignancy Oct. 7 (Fri.) 10:15-11: E14-9 Translational research in breast cancer Oct. 7 (Fri.) 12:50-14: E14-10 Gastric cancer: translational research Oct. 7 (Fri.) 14:05-15: E14-11 Molecular genomic analysis of hematological malignancy Oct. 7 (Fri.) 12:50-14: E14-12 Molecular analysis of hematological malignancy Oct. 7 (Fri.) 14:05-15: E14-13 Translational research in brain tumor Oct. 8 (Sat.) 9:00-10: E14-14 Translational research in pediatric and rare cancers Oct. 8 (Sat.) 10:15-11: J14-1 Diagnosis and treatment model of hepato-biliary-pancreatic cancer Oct. 6 (Thu.) 9:00-10: J14-2 Urological tumor and genome analysis Oct. 6 (Thu.) 9:00-10: J14-3 Diagnosis and treatment model of pancreatic cancer Oct. 6 (Thu.) 12:50-14: J14-4 Lung cancer and mesothelioma Oct. 6 (Thu.) 14:05-15: J14-5 Ovarian cancer and microenvironment Oct. 7 (Fri.) 10:15-11: J14-6 Biomarker of esophageal cancer Oct. 7 (Fri.) 9:00-10: J14-7 Biomarker of colorectal cancer Oct. 7 (Fri.) 10:15-11: J14-8 Breast cancer and endocrine tumor Oct. 7 (Fri.) 14:05-15: J14-9 Biomarker of gastric cancer Oct. 7 (Fri.) 12:50-14: Diagnosis Day Time Room Page E15-1 Novel cancer diagnostic tools and it's application (1) (1) Oct. 7 (Fri.) 9:00-10: E15-2 Novel cancer diagnostic tools and it's application (2) (2) Oct. 7 (Fri.) 10:15-11: J15-1 Diagnostic biomarker Oct. 6 (Thu.) 14:05-15: J15-2 Cancer biology and molecular imaging Oct. 8 (Sat.) 15:05-16: Molecular-targeting therapy Day Time Room Page E16-1 Molecular target therapy (3) (3) Oct. 7 (Fri.) 12:50-14: E16-2 Molecular target therapy (4) (4) Oct. 7 (Fri.) 14:05-15: J16-1 Molecular target therapy (1) (1) Oct. 7 (Fri.) 9:00-10: J16-2 Molecular target therapy (2) (2) Oct. 7 (Fri.) 10:15-11: Chemotherapy and endocrine therapy Day Time Room Page E17-1 Drug delivery systems Oct. 6 (Thu.) 10:15-11: J17-1 DDS, combination therapies DDS Oct. 6 (Thu.) 9:00-10: J17-2 Anticancer compounds Oct. 8 (Sat.) 9:00-10: J17-3 Anticancer drug resistance Oct. 8 (Sat.) 10:15-11: J17-4 Cell death and drug resistance Oct. 8 (Sat.) 13:50-15: Evaluation and prediction of pharmacological effects Day Time Room Page E18-1 Novel biomarkers and diagnostic tools in cancer Oct. 8 (Sat.) 9:00-10: Gene therapy Day Time Room Page E21-1 Oncolytic virus and gene therapy (1) (1) Oct. 8 (Sat.) 9:00-10: J21-1 Oncolytic virus and gene therapy (2) (2) Oct. 8 (Sat.) 10:15-11:

6 24 Epidemiology Day Time Room Page E24-1 Analytical epidemiology of cancer Oct. 8 (Sat.) 13:50-15: Others Day Time Room Page E99-1 Cancer prevention and treatment (2) (2) Oct. 8 (Sat.) 13:50-15: E99-2 Cancer biology and cancer control Oct. 8 (Sat.) 15:05-16: J99-1 Cancer prevention and treatment (1) (1) Oct. 8 (Sat.) 9:00-10: J99-2 Signal transduction and pharmacology Oct. 8 (Sat.) 10:15-11: J99-3 Radiation therapy, bioinformatics and epidemiology Oct. 8 (Sat.) 15:05-16: INFORMATION DAY 1 AM LS PM Posters DAY 2 AM LS PM Posters DAY 3 AM LS PM Posters INDEX Authors Keywords Chairpersons 19

7 Poster Sessions I II Mounting Viewing Discussion(I) Discussion(II) Removal Day 1, Oct. 6 (Thu.) 8:30 10:00 10:00 15:50 15:50 16:35 16:35 17:20 17:20 17:50 Day 2, Oct. 7 (Fri.) 8:30 10:00 10:00 15:50 15:50 16:35 16:35 17:20 17:20 17:50 Day 3, Oct. 8 (Sat.) 8:30 10:00 10:00 16:30 16:30 17:15 17:15 18:00 18:00 18:30 1 Chemical carcinogenesis and radiation carcinogenesis Day Time Page P1-1 Carcinogens Oct. 6 (Thu.) 15:50-16:35 90 P1-2 Carcinogenic stimuli Oct. 6 (Thu.) 16:35-17:20 90 P1-3 Process of carcinogenesis Oct. 8 (Sat.) 16:30-17: P1-4 Oxidative stress Oct. 8 (Sat.) 17:15-18: P1-5 Experimental cell culture systems Oct. 8 (Sat.) 16:30-17: P1-6 Radiation carcinogenesis Oct. 8 (Sat.) 17:15-18: Experimental animal models and genetically-engineered animals Day Time Page P2-1 Gene-manipulated animal models (1) (1) Oct. 7 (Fri.) 15:50-16: P2-2 Gene-manipulated animal models (2) (2) Oct. 7 (Fri.) 16:35-17: P2-3 Animal model for carcinogenesis (1) (1) Oct. 7 (Fri.) 15:50-16: P2-4 Animal model for carcinogenesis (2) (2) Oct. 7 (Fri.) 16:35-17: P2-5 Xenograft model of human cancer Oct. 7 (Fri.) 15:50-16: Virus, infection, inflammation and cancer Day Time Page P3-1 EBV EBV Oct. 7 (Fri.) 16:35-17: P3-2 HPV, HBV, HTLV-1 HPV HBV HTLV-1 Oct. 7 (Fri.) 15:50-16: P3-3 H.pylori and inflammation H.pylori Oct. 7 (Fri.) 16:35-17: Oncogenes and tumor-suppressor genes Day Time Page P4-1 p53-related genes (1) p53 (1) Oct. 7 (Fri.) 15:50-16: P4-2 p53-related genes (2) p53 (2) Oct. 7 (Fri.) 16:35-17: P4-3 Wnt signal Wnt Oct. 7 (Fri.) 15:50-16: P4-4 Cancer-associated genes (1) (1) Oct. 7 (Fri.) 16:35-17: P4-5 Cancer-associated genes (2) (2) Oct. 7 (Fri.) 15:50-16: P4-6 Cancer-associated genes (3) (3) Oct. 7 (Fri.) 16:35-17: P4-7 Cancer-associated genes (4) (4) Oct. 8 (Sat.) 16:30-17: P4-8 Cancer-associated genes (5) (5) Oct. 8 (Sat.) 17:15-18: P4-9 Cancer-associated genes (6) (6) Oct. 8 (Sat.) 16:30-17: Signal transduction and gene expression Day Time Page P5-1 Proliferation/differentiation Oct. 8 (Sat.) 17:15-18: P5-2 Signaling pathway (1) (1) Oct. 8 (Sat.) 16:30-17: P5-3 Signaling pathway (2) (2) Oct. 8 (Sat.) 17:15-18: P5-4 Transcriptional regulation (1) (1) Oct. 8 (Sat.) 16:30-17: P5-5 Transcriptional regulation (2), micro-rna (1) (2) RNA (1) Oct. 8 (Sat.) 17:15-18: P5-6 micro-rna (2) RNA (2) Oct. 8 (Sat.) 16:30-17: P5-7 micro-rna (3) RNA (3) Oct. 8 (Sat.) 17:15-18: P5-8 micro-rna (4) RNA (4) Oct. 8 (Sat.) 16:30-17: DNA replication/cell cycle/genomic instability Day Time Page P6-1 Cell cycle (1) (1) Oct. 8 (Sat.) 17:15-18: P6-2 Cell cycle (2), DNA replication (2) DNA Oct. 8 (Sat.) 16:30-17: P6-3 DNA repair DNA Oct. 8 (Sat.) 17:15-18: P6-4 Genetic instability Oct. 8 (Sat.) 16:30-17: Cancer genome/genetics Day Time Page P7-1 Cancer genome analysis (1) (1) Oct. 6 (Thu.) 15:50-16:35 91 P7-2 Cancer genome analysis (2) (2) Oct. 6 (Thu.) 16:35-17:20 91 P7-3 Cancer genome analysis (3) (3) Oct. 6 (Thu.) 15:50-16:35 92 P7-4 Cancer genome analysis (4) (4) Oct. 6 (Thu.) 16:35-17:20 93 P7-5 Cancer genome analysis (5) (5) Oct. 6 (Thu.) 15:50-16:35 93 P7-6 Familial tumor Oct. 6 (Thu.) 16:35-17:

8 8 Cell death/immortalization Day Time Page P8-1 Apotosis (1) (1) Oct. 8 (Sat.) 17:15-18: P8-2 Apotosis (2) (2) Oct. 8 (Sat.) 16:30-17: P8-3 Telomeres/senescence Oct. 8 (Sat.) 17:15-18: Epigenetics Day Time Page P9-1 DNA methylation (1) DNA (1) Oct. 6 (Thu.) 15:50-16:35 95 P9-2 DNA methylation (2) DNA (2) Oct. 6 (Thu.) 16:35-17:20 96 P9-3 DNA methylation (3) DNA (3) Oct. 6 (Thu.) 15:50-16:35 96 P9-4 DNA methylation (4) DNA (4) Oct. 6 (Thu.) 16:35-17:20 97 P9-5 Histone modification (1) (1) Oct. 7 (Fri.) 15:50-16: P9-6 Histone modification (2) (2) Oct. 7 (Fri.) 16:35-17: P9-7 Epigenetic regulation Oct. 7 (Fri.) 15:50-16: Invasion and metastasis Day Time Page P10-1 Cell adhesion/migration Oct. 6 (Thu.) 15:50-16:35 97 P10-2 Invasion (1) (1) Oct. 6 (Thu.) 16:35-17:20 98 P10-3 Invasion (2) (2) Oct. 6 (Thu.) 15:50-16:35 98 P10-4 Extracellular matrix and protease Oct. 6 (Thu.) 16:35-17:20 99 P10-5 Metastasis-associated genes (1) (1) Oct. 7 (Fri.) 16:35-17: P10-6 Metastasis-associated genes (2) (2) Oct. 7 (Fri.) 15:50-16: P10-7 Angiogenesis Oct. 7 (Fri.) 16:35-17: P10-8 Metastasis diagnosis Oct. 7 (Fri.) 15:50-16: P10-9 Metastasis suppression (1) (1) Oct. 8 (Sat.) 16:30-17: P10-10 Metastasis suppression (2) (2) Oct. 8 (Sat.) 17:15-18: P10-11 Metastasis models (1) (1) Oct. 8 (Sat.) 16:30-17: P10-12 Metastasis models (2) (2) Oct. 8 (Sat.) 17:15-18: Characteristics of cancer cells Day Time Page P11-1 Cancer stem cell (1) (1) Oct. 6 (Thu.) 15:50-16:35 99 P11-2 Cancer stem cell (2) (2) Oct. 6 (Thu.) 16:35-17: P11-3 Cancer stem cell (3) (3) Oct. 6 (Thu.) 15:50-16: P11-4 Cancer stem cell (4) (4) Oct. 6 (Thu.) 16:35-17: P11-5 Cancer stem cell (5) (5) Oct. 6 (Thu.) 15:50-16: P11-6 Cancer stem cell (6) (6) Oct. 6 (Thu.) 16:35-17: P11-7 Cell line and cancer Oct. 7 (Fri.) 16:35-17: P11-8 Metabolome (1) (1) Oct. 7 (Fri.) 15:50-16: P11-9 Metabolome (2) (2) Oct. 7 (Fri.) 16:35-17: P11-10 Cell differentiation and cell-to-cell interaction Oct. 8 (Sat.) 16:30-17: P11-11 Cell-to-cell interaction/adhesion molecules Oct. 8 (Sat.) 17:15-18: P11-12 Glycosylation and glycosyltransferase (1) (1) Oct. 8 (Sat.) 16:30-17: P11-13 Glycosylation and glycosyltransferase (2) (2) Oct. 8 (Sat.) 17:15-18: P11-14 Characteristics of cancer cells Oct. 8 (Sat.) 16:30-17: Cancer immunity Day Time Page P12-1 Tumor antigen Oct. 6 (Thu.) 15:50-16: P12-2 Antitumor effector cells and their induction (1) (1) Oct. 6 (Thu.) 16:35-17: P12-3 Antitumor effector cells and their induction (2) (2) Oct. 6 (Thu.) 15:50-16: P12-4 Vaccination therapy Oct. 6 (Thu.) 16:35-17: P12-5 Antibody therapy (1) (1) Oct. 8 (Sat.) 17:15-18: P12-6 Antibody therapy (2) (2) Oct. 8 (Sat.) 16:30-17: P12-7 Immunotherapy (1) (1) Oct. 8 (Sat.) 17:15-18: P12-8 Immunotherapy (2) (2) Oct. 8 (Sat.) 16:30-17: P12-9 Immunomodaration (1) (1) Oct. 8 (Sat.) 17:15-18: P12-10 Immunomodaration (2) (2) Oct. 8 (Sat.) 16:30-17: Growth factors/cytokines/hormones Day Time Page P13-1 Growth- and differentiation-regulating factors Oct. 6 (Thu.) 15:50-16: P13-2 Growth Factor Receptor Oct. 6 (Thu.) 16:35-17: P13-3 Hormones Oct. 6 (Thu.) 15:50-16: P13-4 TGF-β/Smad TGF-β/Smad Oct. 6 (Thu.) 16:35-17: INFORMATION DAY 1 AM LS PM Posters DAY 2 AM LS PM Posters DAY 3 AM LS PM Posters INDEX Authors Keywords Chairpersons 21

9 22 14 Cancer basic, diagnosis and treatment Day Time Page P14-1 Gastric cancer (1) (1) Oct. 6 (Thu.) 15:50-16: P14-2 Gastric cancer (2) (2) Oct. 6 (Thu.) 16:35-17: P14-3 Gastric cancer (3) (3) Oct. 6 (Thu.) 15:50-16: P14-4 Gastric cancer (4) (4) Oct. 6 (Thu.) 16:35-17: P14-5 Gastric cancer (5) (5) Oct. 6 (Thu.) 15:50-16: P14-6 Esophageal cancer (1) (1) Oct. 6 (Thu.) 16:35-17: P14-7 Esophageal cancer (2) (2) Oct. 6 (Thu.) 15:50-16: P14-8 Esophageal cancer (3) (3) Oct. 6 (Thu.) 16:35-17: P14-9 Colorectal cancer (1) (1) Oct. 6 (Thu.) 15:50-16: P14-10 Colorectal cancer (2) (2) Oct. 6 (Thu.) 16:35-17: P14-11 Colorectal cancer (3) (3) Oct. 6 (Thu.) 15:50-16: P14-12 Colorectal cancer (4) (4) Oct. 6 (Thu.) 16:35-17: P14-13 Colorectal cancer (5) (5) Oct. 6 (Thu.) 15:50-16: P14-14 Colorectal cancer (6) (6) Oct. 6 (Thu.) 16:35-17: P14-15 Hepatocellular cancer (1) (1) Oct. 6 (Thu.) 15:50-16: P14-16 Hepatocellular cancer (2) (2) Oct. 6 (Thu.) 16:35-17: P14-17 Hepatocellular cancer (3) (3) Oct. 6 (Thu.) 15:50-16: P14-18 GIST/ biliary tract cancer GIST Oct. 6 (Thu.) 16:35-17: P14-19 Pancreatic cancer (1) (1) Oct. 6 (Thu.) 15:50-16: P14-20 Pancreatic cancer (2) (2) Oct. 6 (Thu.) 16:35-17: P14-21 Lung cancer (1) (1) Oct. 6 (Thu.) 15:50-16: P14-22 Lung cancer (2) (2) Oct. 6 (Thu.) 16:35-17: P14-23 Lung cancer (3) (3) Oct. 6 (Thu.) 15:50-16: P14-24 Lung cancer (4) (4) Oct. 6 (Thu.) 16:35-17: P14-25 Lung cancer (5) (5) Oct. 6 (Thu.) 15:50-16: P14-26 Uterine cancer (1) (1) Oct. 6 (Thu.) 16:35-17: P14-27 Uterine cancer (2) (2) Oct. 6 (Thu.) 15:50-16: P14-28 Ovarian cancer (1) (1) Oct. 6 (Thu.) 16:35-17: P14-29 Ovarian cancer (2) (2) Oct. 6 (Thu.) 15:50-16: P14-30 Breast cancer (1) (1) Oct. 7 (Fri.) 15:50-16: P14-31 Breast cancer (2) (2) Oct. 7 (Fri.) 16:35-17: P14-32 Breast cancer (3) (3) Oct. 7 (Fri.) 15:50-16: P14-33 Breast cancer (4) (4) Oct. 7 (Fri.) 16:35-17: P14-34 Breast cancer (5) (5) Oct. 7 (Fri.) 15:50-16: P14-35 Hematopoietic malignancy (1) (1) Oct. 7 (Fri.) 16:35-17: P14-36 Hematopoietic malignancy (2) (2) Oct. 7 (Fri.) 15:50-16: P14-37 Hematopoietic malignancy (3) (3) Oct. 7 (Fri.) 16:35-17: P14-38 Renal cell cancer (1) (1) Oct. 7 (Fri.) 15:50-16: P14-39 Renal cell cancer (2) (2) Oct. 7 (Fri.) 16:35-17: P14-40 Renal cell cancer (3) (3) Oct. 7 (Fri.) 15:50-16: P14-41 Bladder cancer (1) (1) Oct. 7 (Fri.) 16:35-17: P14-42 Bladder cancer (2) (2) Oct. 7 (Fri.) 15:50-16: P14-43 Bladder cancer (3) (3) Oct. 7 (Fri.) 16:35-17: P14-44 Prostate cancer (1) (1) Oct. 7 (Fri.) 15:50-16: P14-45 Prostate cancer (2) (2) Oct. 7 (Fri.) 16:35-17: P14-46 Prostate cancer (3) (3) Oct. 7 (Fri.) 15:50-16: P14-47 Prostate cancer (4) (4) Oct. 7 (Fri.) 16:35-17: P14-48 Brain tumor (1) (1) Oct. 7 (Fri.) 15:50-16: P14-49 Brain tumor (2) (2) Oct. 7 (Fri.) 16:35-17: P14-50 Soft tissue sarcoma (1) (1) Oct. 7 (Fri.) 15:50-16: P14-51 Soft tissue sarcoma (2) (2) Oct. 7 (Fri.) 16:35-17: P14-52 Head and neck cancer (1) (1) Oct. 7 (Fri.) 15:50-16: P14-53 Head and neck cancer (2) (2) Oct. 7 (Fri.) 16:35-17: P14-54 Head and neck cancer (3) (3) Oct. 7 (Fri.) 15:50-16: P14-55 Head and neck cancer (4) (4) Oct. 7 (Fri.) 16:35-17: P14-56 Head and neck cancer (5) (5) Oct. 7 (Fri.) 15:50-16: P14-57 Pediatric cancer Oct. 7 (Fri.) 16:35-17: P14-58 Non-epithelial tumor Oct. 7 (Fri.) 15:50-16:35 188

10 15 Diagnosis Day Time Page P15-1 Pathological diagnosis Oct. 6 (Thu.) 16:35-17: P15-2 Biomarkers and tumor markers (1) (1) Oct. 7 (Fri.) 16:35-17: P15-3 Biomarkers and tumor markers (2) (2) Oct. 7 (Fri.) 15:50-16: P15-4 Biomarkers and tumor markers (3) (3) Oct. 7 (Fri.) 16:35-17: P15-5 Biomarkers and tumor markers (4) (4) Oct. 7 (Fri.) 15:50-16: P15-6 Genetic diagnosis Oct. 8 (Sat.) 17:15-18: P15-7 New diagnostic technology (1) (1) Oct. 8 (Sat.) 16:30-17: P15-8 New diagnostic technology (2) (2) Oct. 8 (Sat.) 17:15-18: Molecular-targeting therapy Day Time Page P16-1 Signal transduction inhibitors/kinase inhibitors (1) (1) Oct. 7 (Fri.) 16:35-17: P16-2 Signal transduction inhibitors/kinase inhibitors (2) (2) Oct. 7 (Fri.) 15:50-16: P16-3 Signal transduction inhibitors/kinase inhibitors (3) (3) Oct. 7 (Fri.) 16:35-17: P16-4 Signal transduction inhibitors/kinase inhibitors (4) (4) Oct. 7 (Fri.) 15:50-16: P16-5 Angiogenesis inhibitors Oct. 7 (Fri.) 16:35-17: P16-6 Novel targeting drugs (1) (1) Oct. 7 (Fri.) 15:50-16: P16-7 Novel targeting drugs (2) (2) Oct. 7 (Fri.) 16:35-17: P16-8 Novel targeting drugs (3) (3) Oct. 7 (Fri.) 15:50-16: P16-9 Novel targeting drugs (4) (4) Oct. 7 (Fri.) 16:35-17: Chemotherapy and endocrine therapy Day Time Page P17-1 Natural substances (1) (1) Oct. 6 (Thu.) 15:50-16: P17-2 Natural substances (2) (2) Oct. 6 (Thu.) 16:35-17: P17-3 Synthetic anticancer compounds (1) (1) Oct. 6 (Thu.) 15:50-16: P17-4 Synthetic anticancer compounds (2) (2) Oct. 6 (Thu.) 16:35-17: P17-5 Anticancer drug and cell death (1) (1) Oct. 6 (Thu.) 15:50-16: P17-6 Anticancer drug and cell death (2) (2) Oct. 6 (Thu.) 16:35-17: P17-7 Anticancer drug resistance (1) (1) Oct. 8 (Sat.) 16:30-17: P17-8 Anticancer drug resistance (2) (2) Oct. 8 (Sat.) 17:15-18: P17-9 Anticancer drug resistance (3) (3) Oct. 8 (Sat.) 16:30-17: P17-10 Drug delivery system (1) (1) Oct. 8 (Sat.) 17:15-18: P17-11 Drug delivery system (2) (2) Oct. 8 (Sat.) 16:30-17: P17-12 Combinational therapy, adjuvant therapy Oct. 8 (Sat.) 17:15-18: Evaluation and prediction of pharmacological effects Day Time Page P18-1 Drug sensitivity, drug resistance-relating factors and gene expression analysis (1) (1) Oct. 8 (Sat.) 16:30-17: P18-2 Drug sensitivity, drug resistance-relating factors and gene expression analysis (2) (2) Oct. 8 (Sat.) 17:15-18: P18-3 Sensitivity test Oct. 8 (Sat.) 16:30-17: Radiation therapy Day Time Page P19-1 Radiation and particle ray therapy Oct. 8 (Sat.) 17:15-18: P19-2 Efficacy enhancement and hyperthermia Oct. 8 (Sat.) 16:30-17: Cell therapy and regeneration medicine Day Time Page P20-1 Stem cell and cell therapy Oct. 8 (Sat.) 17:15-18: Gene therapy Day Time Page P21-1 Development and modification of vectors Oct. 8 (Sat.) 16:30-17: P21-2 Gene therapy (1) (1) Oct. 8 (Sat.) 17:15-18: P21-3 Gene therapy (2) (2) Oct. 8 (Sat.) 16:30-17: Medical care of progressive cancer Day Time Page P22-1 Palliative treatment and care Oct. 8 (Sat.) 17:15-18: P22-2 Medical care of progressive cancer Oct. 8 (Sat.) 16:30-17: Cancer prevention/chemoprevention Day Time Page P23-1 Chemical agents and cancer prevention Oct. 8 (Sat.) 17:15-18: P23-2 Dietary/alimentary factors Oct. 8 (Sat.) 16:30-17: P23-3 Natural products (1) (1) Oct. 8 (Sat.) 17:15-18: P23-4 Natural products (2) (2) Oct. 8 (Sat.) 16:30-17: INFORMATION DAY 1 AM LS PM Posters DAY 2 AM LS PM Posters DAY 3 AM LS PM Posters INDEX Authors Keywords Chairpersons 23

11 24 Epidemiology Day Time Page P24-1 Cancer risk factors Oct. 8 (Sat.) 17:15-18: P24-2 Epidemiology Oct. 8 (Sat.) 16:30-17: Information/informatics Day Time Page P25-1 Bioinfomatics (1) (1) Oct. 8 (Sat.) 17:15-18: P25-2 Bioinfomatics (2) (2) Oct. 8 (Sat.) 16:30-17: Cancer and society Day Time Page P26-1 Cancer & society Oct. 8 (Sat.) 17:15-18: